Skip to content

Dietary Approaches for Cardiometabolic Health

Dietary Approaches for Improving Cardiometabolic Health

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03527290
Acronym
DACH
Enrollment
30
Registered
2018-05-17
Start date
2018-01-15
Completion date
2020-11-05
Last updated
2021-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Dyslipidemias, Insulin Resistance, Obesity, Abdominal, Weight Loss

Brief summary

This pilot study aims to recruit 30 adults with abdominal obesity, without major chronic disease, and test whether clinical dietary advice that is solely focused on the timing of eating (time restricted eating), has an effect on cardiometabolic health compared to standard dietary advice for cardiometabolic health, which is focused on content. The goal of this pilot study is to develop and hone dietary counseling approaches for time restricted eating for RD's in a clinical practice paradigm, and collect data on testing this intervention compared to standard dietary counseling approaches for cardiometabolic health.

Interventions

BEHAVIORALTime Restricted Eating

The intervention is delivered in a paradigm in which an individual with abdominal obesity would be referred by their physician to receive dietary counseling from a Registered Dietitian (RD). The aim of the intervention is to improve cardiometabolic health and assist with weight management via 4, individualized counseling sessions over the course of 8 weeks. Participants are educated on basic concepts related to circadian rhythms, metabolism and TRE; and the evidence demonstrating benefit of TRE in animal models and humans. The goal is provide rationale for the potential benefits of a TRE approach. In addition, the RD sessions focus on developing a plan for successfully implementing a TRE approach, identifying challenges for adherence, and a plan for dealing with real or potential challenges. The counseling is focused the TRE concept, with no specific direction or counseling related to modifying the content of the participant's diet or any prescription to reduce energy intake.

BEHAVIORALStandard Cardiometabolic Health Diet

The intervention is delivered in a paradigm in which an individual with abdominal obesity would be referred by their physician to receive dietary counseling from a Registered Dietitian (RD). The aim of the intervention is to improve cardiometabolic health and assist with weight management via 4, individualized counseling sessions over the course of 8 weeks. Participants are educated on basic concepts and known benefits related to eating a diet for cardiometabolic health and weight management recommended by the American Heart Association and the Academy of Nutrition and Dietetics as a standard of practice for dietitians in healthcare settings. The RD sessions focus on adopting a dietary pattern aligned with this approach, identifying challenges to adopting this dietary pattern, and education and plans for dealing with real or potential challenges. The counseling gives no direction related to modifying the timing of dietary intake or any prescription to reduce energy intake.

Sponsors

University of California, Irvine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Participants are blinded to the nature of the other intervention so as not to contaminate the intervention. The clinical research staff taking the measurements is also blinded to the respective intervention the participant has been randomized to.

Eligibility

Sex/Gender
ALL
Age
22 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Abdominal obesity (waist circumference ≥35 for women and ≥40 for men; if Asian ethnicity, ≥35 for men and ≥31.5 for women) * weight stable over the previous 2 months * medications stable for \> 3 months * self-reported 24-hr sleep-wake patterns within the appropriate range as defined by the National Sleep Foundation (self-reported habitual sleep duration 6-10 hours during nocturnal hours) * regular meal patterns * from the greater UCI and Orange county area * willing to incorporate a dietary approach aimed at improving cardiometabolic health and weight management * able to speak, read and understand English or Spanish

Exclusion criteria

* Self-reported unstable hypertension * Type 1 or 2 diabetes mellitus * heart, renal, or liver disease * cancer or active neoplasms * hyperthyroidism unless treated and under control * taking any medications known to affect clinical risk measures of interest or weight/energy expenditure (except for stable blood pressure medication) * active usual smoking (tobacco or marijuana) * alcohol intake \> 3 drinks/day * pregnancy, current lactation, or plans to become pregnant during the study

Design outcomes

Primary

MeasureTime frameDescription
Triglyceride : HDL cholesterol ratio8 weeksRatio of fasting triglycerides to HDL cholesterol

Secondary

MeasureTime frameDescription
HOMA-IR8 weeksEstimation of HOMA-IR from fasting glucose and insulin
Glucose8 weeksFasting glucose
Insulin8 weeksFasting insulin
LDL cholesterol8 weeksLDL cholesterol
Weight8 weeksBody weight measured on calibrated scale
Diet QualityRun-in (up to 2 weeks), Intervention (8 weeks)Assessed by 2 unannounced recalls during run-in period and 3 during intervention
Post-hoc estimated energy intake8 weeksEstimated by utilizing NIDDK Body weight planner with weights measured over 8 weeks
Objective sleep and physical activity habitsRun-in (up to 2 weeks), Intervention (8 weeks)Measured with fitbit
Blood pressure8 weeksResting systolic and diastolic blood pressure
Waist Circumference8 weeksMeasured by standard approach utilized in NHANES

Other

MeasureTime frameDescription
Eating durationRun-in (up to 2 weeks), Intervention (8 weeks)Glycemic data from blinded continuous glucose monitor to estimate actual daily eating period

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026